Terms: = Germ cell tumor AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S
166 results:
1. Metabolomics-transcriptomics joint analysis: unveiling the dysregulated cell death network and developing a diagnostic model for high-grade neuroblastoma.
Zhang W; Zhang M; Sun M; Hu M; Yu M; Sun J; Zhang X; Du B
Front Immunol; 2023; 14():1345734. PubMed ID: 38239355
[TBL] [Abstract] [Full Text] [Related]
2. Systematic characterization of antibody-drug conjugate targets in central nervous system tumors.
Coy S; Lee JS; Chan SJ; Woo T; Jones J; Alexandrescu S; Wen PY; Sorger PK; Ligon KL; Santagata S
Neuro Oncol; 2024 Mar; 26(3):458-472. PubMed ID: 37870091
[TBL] [Abstract] [Full Text] [Related]
3. Molecular and clinical correlates of her3 expression highlights its potential role as a therapeutic target in melanoma.
Shteinman ER; Vergara IA; Rawson RV; Lo SN; Maeda N; Koyama K; da Silva IP; Long GV; Scolyer RA; Wilmott JS; Menzies AM
Pathology; 2023 Aug; 55(5):629-636. PubMed ID: 37286471
[TBL] [Abstract] [Full Text] [Related]
4. Collectin-11 promotes cancer cell proliferation and tumor growth.
Wang JX; Cao B; Ma N; Wu KY; Chen WB; Wu W; Dong X; Liu CF; Gao YF; Diao TY; Min XY; Yong Q; Li ZF; Zhou W; Li K
JCI Insight; 2023 Mar; 8(5):. PubMed ID: 36883567
[TBL] [Abstract] [Full Text] [Related]
5. Efficient Muscle Regeneration by Human PSC-Derived CD82
Xie N; Chu SN; Schultz CB; Chan SSK
Cells; 2023 Jan; 12(3):. PubMed ID: 36766703
[TBL] [Abstract] [Full Text] [Related]
6. Cooperative induction of receptor tyrosine kinases contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathway.
Alver TN; Heintz KM; Hovig E; Bøe SL
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1736. PubMed ID: 36251678
[TBL] [Abstract] [Full Text] [Related]
7. Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants.
Przybyła W; Gjersvoll Paulsen KM; Mishra CK; Nygård S; Engebretsen S; Ruud E; Trøen G; Beiske K; Baumbusch LO
PLoS One; 2022; 17(8):e0273280. PubMed ID: 36037157
[TBL] [Abstract] [Full Text] [Related]
8. Defining the Skeletal Myogenic Lineage in Human Pluripotent Stem cell-Derived Teratomas.
Pappas MP; Xie N; Penaloza JS; Chan SSK
Cells; 2022 May; 11(9):. PubMed ID: 35563894
[TBL] [Abstract] [Full Text] [Related]
9. Targeting erbb3 and cellular NADPH/NADP
Leu JI; Murphy ME; George DL
ACS Chem Biol; 2022 May; 17(5):1038-1044. PubMed ID: 35420772
[TBL] [Abstract] [Full Text] [Related]
10. Nucleolar localization of the erbb3 receptor as a new target in glioblastoma.
Tagliaferro M; Rosa P; Bellenchi GC; Bastianelli D; Trotta R; Tito C; Fazi F; Calogero A; Ponti D
BMC Mol Cell Biol; 2022 Mar; 23(1):13. PubMed ID: 35255831
[TBL] [Abstract] [Full Text] [Related]
11. erbb3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to erbb3 targeting in glioblastoma.
De Bacco F; Orzan F; Erriquez J; Casanova E; Barault L; Albano R; D'Ambrosio A; Bigatto V; Reato G; Patanè M; Pollo B; Kuesters G; Dell'Aglio C; Casorzo L; Pellegatta S; Finocchiaro G; Comoglio PM; Boccaccio C
Cell Rep; 2021 Jul; 36(4):109455. PubMed ID: 34320350
[TBL] [Abstract] [Full Text] [Related]
12. The expression and prognostic value of the epidermal growth factor receptor family in glioma.
Xu B; Huo Z; Huang H; Ji W; Bian Z; Jiao J; Sun J; Shao J
BMC Cancer; 2021 Apr; 21(1):451. PubMed ID: 33892666
[TBL] [Abstract] [Full Text] [Related]
13. The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis.
Hoesl C; Fröhlich T; Posch C; Kneitz H; Goebeler M; Schneider MR; Dahlhoff M
Mol Oncol; 2021 Aug; 15(8):2140-2155. PubMed ID: 33786987
[TBL] [Abstract] [Full Text] [Related]
14. Glioma pathogenesis-related protein 1 performs dual functions in tumor cells.
Wang J; Li Z; Yin F; Zhang R; Zhang Y; Wang Z; Sheng X
Cancer Gene Ther; 2022 Mar; 29(3-4):253-263. PubMed ID: 33742130
[TBL] [Abstract] [Full Text] [Related]
15. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y
Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892
[TBL] [Abstract] [Full Text] [Related]
16. Identification of Genomic Alterations in Sporadic Pancreatic Neurogenic tumors.
Wang XY; Cai JP; Song LL; Huang CS; Chen W; Huang XT; Chen SF; Liu XY; Yin XY
Pancreas; 2020; 49(10):1393-1397. PubMed ID: 33122531
[TBL] [Abstract] [Full Text] [Related]
17. MicroRNA miR-100 Decreases Glioblastoma Growth by Targeting SMARCA5 and erbb3 in tumor-Initiating cells.
Alrfaei BM; Clark P; Vemuganti R; Kuo JS
Technol Cancer Res Treat; 2020; 19():1533033820960748. PubMed ID: 32945237
[TBL] [Abstract] [Full Text] [Related]
18. cell Lineage-Based Stratification for Glioblastoma.
Wang Z; Sun D; Chen YJ; Xie X; Shi Y; Tabar V; Brennan CW; Bale TA; Jayewickreme CD; Laks DR; Alcantara Llaguno S; Parada LF
Cancer Cell; 2020 Sep; 38(3):366-379.e8. PubMed ID: 32649888
[TBL] [Abstract] [Full Text] [Related]
19. Comparison between CT and MRI in detection of metastasis of the retroperitoneum in testicular germ cell tumors: a prospective trial.
Laukka M; Mannisto S; Beule A; Kouri M; Blomqvist C
Acta Oncol; 2020 Jun; 59(6):660-665. PubMed ID: 32048533
[No Abstract] [Full Text] [Related]
20. Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma.
Tiago M; Capparelli C; Erkes DA; Purwin TJ; Heilman SA; Berger AC; Davies MA; Aplin AE
Br J Cancer; 2020 Mar; 122(6):789-800. PubMed ID: 31932756
[TBL] [Abstract] [Full Text] [Related]
[Next]
